Cargando…

Prevalence and Characteristics of Cystic Fibrosis in Omani Children: A Multi-center Cross-sectional Study

OBJECTIVES: To describe the demographic distribution of cystic fibrosis (CF) in Omani children, estimate the national prevalence, and provide updated mutational panels of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. METHODS: We conducted a retrospective cross-sectional study...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Oraimi, Sumaya, Al Shidhani, Khoula, Al Harthi, Hasina, Al Sinani, Suaad, Al Busaidi, Nasser, Al Bimani, Muna, Al Salmi, Qasem, Al Kindi, Hussein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OMJ 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627948/
https://www.ncbi.nlm.nih.gov/pubmed/36458240
http://dx.doi.org/10.5001/omj.2022.101
Descripción
Sumario:OBJECTIVES: To describe the demographic distribution of cystic fibrosis (CF) in Omani children, estimate the national prevalence, and provide updated mutational panels of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. METHODS: We conducted a retrospective cross-sectional study of all CF patients who had been diagnosed and followed-up at Sultan Qaboos University Hospital and Royal Hospital in Oman between 2006 and 2020. Data were collected from electronic hospital records and telephone interviews. RESULTS: A total of 227 patients with CF were included in the study. Geographical clusters of the disease were identified in the governorates of Al-Batinah, A’Dhahirah, and A’Dakhiliyah. Parental consanguinity and family history of CF were present in 68.3% and 69.6% of the patients, respectively. The most common CFTR mutation was p.Ser549Arg (52.0%), followed by p.Phe508del (12.3%), and c.2988+1G>A (4.4%). Three novel CFTR mutations were identified, viz., Leu88TyrFs*, p.Asp192Val, and c.4242+1G>C. CONCLUSIONS: The estimated prevalence of CF in Oman is 10.3 per 100 000 individuals. Premarital genetic counseling and preimplantation genetic testing are recommended in CF-prevalent regions.